ADUS vs GLPG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ADUS exhibits mixed financial health with a Piotroski F-Score of 4/9, indicating a weak to stable foundation, and no Altman Z-Score available, which limits distress risk assessment. The stock trades at $101.35, below its intrinsic value of $153.99 and Graham Number of $83.83, suggesting potential undervaluation on a defensive basis. However, strong revenue and earnings growth (25.6% and 52.1% YoY) are tempered by bearish insider activity and a lack of dividend. Analysts maintain a 'buy' recommendation with a target of $140.23, reflecting optimism in future performance.
GLPG presents a classic 'value trap' profile: while the Graham Number ($84.09) and Intrinsic Value ($163.14) suggest massive undervaluation, the Piotroski F-Score of 2/9 indicates severely weak fundamental health. The company boasts a pristine balance sheet with zero debt and an extraordinary current ratio of 20.14, yet the market is pricing it at a 66% discount to its defensive fair value. This discrepancy, combined with a negative forward P/E and a 0/100 technical trend, suggests the market anticipates a significant reversal of recent growth spikes.
Compare Another Pair
Related Comparisons
ADUS vs GLPG: Head-to-Head Comparison
This page compares Addus HomeCare Corporation (ADUS) and Galapagos NV (GLPG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.